marijuana stocks news

Stevia Corp. (STEV)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 255   515   2,217   4,479  
Cost of Revenue 258 71 1,737 4,425
Gross Profit (3) 444   480   54  
Operating Expenses
Research Development 40 86 96 26
Selling General and Administrative 243 445 278 985
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (286) (87) 106   (956)
Income from Continuing Operations
Total Other Income/Expenses Net (901) (357) 1,908 (6,147)
Earnings Before Interest And Taxes (1,187) (443) 2,014 (7,103)
Interest Expense 20 11 53 65
Income Before Tax (1,208) (455) 1,962 (7,168)
Income Tax Expense
Minority Interest 22 24 28 (53)
Net Income From Continuing Ops (1,185) (431) 1,990 (7,221)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,185) (431) 1,990   (7,221)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,185) (431) 1,990   (7,221)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) to Present at the Virtual 19th Annual Needham Healthcare Conference

Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Conference…

$VHUB CFO, CEO to Present at LD Micro Invitational Investor Conference

Vapor Hub International CFO, CEO to Present at LD Micro Invitational Investor…

Curaleaf Holdings, Inc. (CURLF) Expands Retail Presence in Florida with Grand Opening of Spring Hill Dispensary

Curaleaf Expands Retail Presence in Florida with Grand Opening of Spring Hill…

$CARA Positive Data From Quantitative Phase 1 Trial

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory…